Monday, September 22, 2014   

Novartis bosses in Japan shown the door
(04-03 14:03)

Swiss pharmaceutical giant Novartis said it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.
David Epstein, the head of the firm's pharmaceutical division, told a news briefing in Tokyo that the senior managers “resigned, they are out of the company,’’ adding that “this kind of behavior is unacceptable and a clear violation of our code of conduct''.
--AFP
   
Other Business breaking news:
China sentences GSK officials to 2-4 years in prison: Xinhua (09-19 17:05)
China's total loan demand dampens in Q3: survey (09-19 16:51)
Drugmaker GSK fined in China graft probe: report (09-19 16:50)
Hang Seng tracks Street gains (09-19 16:43)
Alibaba sets IPO share price at US$68 (09-19 15:39)
London stocks surge after Scotland rejects independence (09-19 15:38)
Japan downgrades economic assessment as PM promises reform (09-19 14:03)
Chinese buyers lead charge in iPhone 6 global debut (09-19 13:25)
Hang Seng dips, Shanghai gains (09-18 16:17)
Nikkei jumps on weaker yen (09-18 14:44)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.